Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report) SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Henry Schein Stock Up 0.1 %
Shares of NASDAQ:HSIC opened at $68.89 on Tuesday. The company has a 50 day moving average of $68.95 and a 200-day moving average of $70.77. Henry Schein, Inc. has a one year low of $60.01 and a one year high of $82.63. The stock has a market cap of $8.73 billion, a price-to-earnings ratio of 23.27, a P/E/G ratio of 1.93 and a beta of 0.86. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90.
Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, beating analysts' consensus estimates of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The firm had revenue of $3.10 billion for the quarter, compared to analyst estimates of $3.27 billion. During the same quarter in the previous year, the firm posted $1.31 earnings per share. The business's revenue was up .0% on a year-over-year basis. On average, sell-side analysts forecast that Henry Schein, Inc. will post 4.75 earnings per share for the current year.
Hedge Funds Weigh In On Henry Schein
Kamala’s Dirty Election Move… Revealed
From Paradigm Press | Ad
According to former advisor to the CIA, the Pentagon and the White House Jim Rickards…
Kamala and her puppet masters are planning this dirty election move…
Click here now and learn how to prepare.
A number of institutional investors have recently added to or reduced their stakes in HSIC. Victory Capital Management Inc. boosted its position in shares of Henry Schein by 10.9% in the fourth quarter. Victory Capital Management Inc. now owns 151,657 shares of the company's stock valued at $11,482,000 after acquiring an additional 14,868 shares during the period. Benjamin F. Edwards & Company Inc. increased its position in Henry Schein by 37.8% during the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 1,516 shares of the company's stock valued at $114,000 after purchasing an additional 416 shares during the period. National Bank of Canada FI grew its position in shares of Henry Schein by 5.2% during the 4th quarter. National Bank of Canada FI now owns 39,153 shares of the company's stock worth $2,958,000 after buying an additional 1,950 shares during the period. Charles Schwab Investment Management Inc. grew its position in shares of Henry Schein by 2.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,137,623 shares of the company's stock worth $86,129,000 after buying an additional 29,683 shares during the period. Finally, BNP Paribas Financial Markets grew its position in shares of Henry Schein by 36.0% during the 4th quarter. BNP Paribas Financial Markets now owns 82,517 shares of the company's stock worth $6,247,000 after buying an additional 21,838 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several brokerages have recently commented on HSIC. Robert W. Baird decreased their price objective on Henry Schein from $92.00 to $82.00 and set an "outperform" rating for the company in a report on Wednesday, August 7th. Evercore ISI lowered their target price on Henry Schein from $72.00 to $70.00 and set an "in-line" rating on the stock in a report on Wednesday, August 7th. Piper Sandler reaffirmed an "overweight" rating and set a $86.00 price target on shares of Henry Schein in a research report on Friday, June 21st. JPMorgan Chase & Co. dropped their price target on shares of Henry Schein from $88.00 to $80.00 and set an "overweight" rating for the company in a research note on Monday, August 12th. Finally, Barrington Research decreased their price objective on shares of Henry Schein from $92.00 to $82.00 and set an "outperform" rating for the company in a research note on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, Henry Schein currently has an average rating of "Hold" and a consensus target price of $77.10.
View Our Latest Stock Report on HSIC
Henry Schein Company Profile
(
Get Free Report)
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
